HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Industry Roundup: GMP Warnings, Spiked Product Recall, UK Ads

This article was originally published in The Tan Sheet

Executive Summary

Food or supplement at Summit Beverage? Merck & Co. venture arm adds European director; meetings on import safety programs; and more news in brief.

You may also be interested in...



Health, Beauty And Wellness News: GNC, Momentous, Nutrition 21, Gaspari

GNC online sourcing deal; Gaspari CEO has full control of brand; medical cannabis research partnership in Canada; Momentous occasion of plant protein launch; Innotech Nutrition in US with Colflex preventative spray; AMP Energy wants entrepreneurs; and Nutrition 21's Nitrosigine in C4 Ultimate Shred.

FDA Targets Riddhi GMP Failures: Health And Wellness Industry News In Brief

Complaint filed to shut down Riddhi USA; GOED introduces guidelines to assist industry in preventing oxidation of EPA/DHA oils; UK says B-Life breached ad codes by claiming its ADrop water ionizer can improve health, specifically diabetes; and more health and wellness news in brief.

Hi-Tech CEO Wheat Arrested In FDA Investigation Of Steroid-Spiked Supplements

Hi-Tech Pharmaceuticals CEO Jared Wheat and an associate face 18 criminal charges in federal court alleging they falsified FDA documents and distributed as supplements products containing steroid ingredient. Wheat is appealing the indictment to federal circuit court.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS108900

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel